230 related articles for article (PubMed ID: 22951242)
1. Discussion: a fresh look at monoamine oxidase inhibitors for depression.
Cohen LJ; Sclar DA; Culpepper L; Flockhart DA; Hirschfeld RM; Thase ME; VanDenBerg CM
J Clin Psychiatry; 2012; 73 Suppl 1():42-5. PubMed ID: 22951242
[No Abstract] [Full Text] [Related]
2. The use of monoamine oxidase inhibitors in primary care.
Culpepper L
J Clin Psychiatry; 2012; 73 Suppl 1():37-41. PubMed ID: 22951241
[TBL] [Abstract][Full Text] [Related]
3. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
Flockhart DA
J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238
[TBL] [Abstract][Full Text] [Related]
4. Introduction: a fresh look at monoamine oxidase inhibitors for depression.
Cohen LJ; Sclar DA
J Clin Psychiatry; 2012; 73 Suppl 1():3-4. PubMed ID: 22951235
[No Abstract] [Full Text] [Related]
5. The role of monoamine oxidase inhibitors in depression treatment guidelines.
Thase ME
J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
[TBL] [Abstract][Full Text] [Related]
6. [MAO-inhibitors--a treatment option for treatment resistant depression: application, efficacy and characteristics].
Köhler S; Stöver LA; Bschor T
Fortschr Neurol Psychiatr; 2014 Apr; 82(4):228-36; quiz 237-8. PubMed ID: 24710679
[No Abstract] [Full Text] [Related]
7. Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure.
Cohen LJ; Sclar DA
J Clin Psychiatry; 2012; 73 Suppl 1():31-6. PubMed ID: 22951240
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase inhibitors revisited: what you should know.
Goldberg JF; Thase ME
J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
[No Abstract] [Full Text] [Related]
9. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
Kennedy SH
J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
[TBL] [Abstract][Full Text] [Related]
10. The transdermal delivery system of monoamine oxidase inhibitors.
VanDenBerg CM
J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239
[TBL] [Abstract][Full Text] [Related]
11. Psychopharmacology column: why choose selegiline transdermal system for refractory depression?
Tobin M
Issues Ment Health Nurs; 2007 Feb; 28(2):223-8. PubMed ID: 17365170
[No Abstract] [Full Text] [Related]
12. Revisiting monoamine oxidase inhibitors.
Krishnan KR
J Clin Psychiatry; 2007; 68 Suppl 8():35-41. PubMed ID: 17640156
[TBL] [Abstract][Full Text] [Related]
13. The Concurrent Treatment With Intravenous Ketamine and an Irreversible Monoamine Oxidase Inhibitor for Treatment-Resistant Depression Without Hypertensive Crises.
Wang JCC; Swainson J
J Clin Psychopharmacol; 2020; 40(5):515-517. PubMed ID: 32740556
[No Abstract] [Full Text] [Related]
14. STAR*D: a summary and UK perspective.
Deakin J; O'Loughlin C
J Psychopharmacol; 2009 Aug; 23(6):605-12. PubMed ID: 19395428
[No Abstract] [Full Text] [Related]
15. Tranylcypromine and bupropion combination therapy in treatment-resistant major depression: a report of 2 cases.
Quante A; Zeugmann S
J Clin Psychopharmacol; 2012 Aug; 32(4):572-4. PubMed ID: 22760351
[No Abstract] [Full Text] [Related]
16. MAOIs: issues in treatment adherence and rates of treatment failure.
Cohen LJ; Sclar DA
J Clin Psychiatry; 2013 Jan; 74(1):e02. PubMed ID: 23419230
[TBL] [Abstract][Full Text] [Related]
17. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
[TBL] [Abstract][Full Text] [Related]
18. [The use of the monoamine oxidase inhibitor isocarboxazide in treatment-resistant depression].
Larsen JK; Krogh-Nielsen L; Brøsen K
Ugeskr Laeger; 2015 Dec; 177(52):V06150499. PubMed ID: 26692222
[TBL] [Abstract][Full Text] [Related]
19. [Are monoamine oxidase inhibitors coming back?].
Nolen WA
Ned Tijdschr Geneeskd; 1985 Aug; 129(33):1571-6. PubMed ID: 4047207
[No Abstract] [Full Text] [Related]
20. [High dosage tranylcypromine treatment of "therapy refractory" depressions].
Schmauss M
Nervenarzt; 1996 May; 67(5):390-3. PubMed ID: 9005348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
